Sabejon, Jes Russel A.
HRN: 23-60-32 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/26/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
08/26/2023
09/02/2023
IVT
130mg
Q8
Amoebiasis
Checking Final Appropriateness
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes